-
He said he wasn't told why the TB division didn't endorse the effort but said it might have been because a written proposal wasn't submitted.
WSJ: Plan to Fight Deadly TB Strain Advances in India
-
For doctors who don't specialize in TB, treatment of resistant strains gets tricky.
WSJ: TB's Global Resurgence Amplifies U.S. Risk
-
"We simply can't go on while TB increases its vice-like grip on family farms" argues the president of the NFU Peter Kendall.
BBC: Badgers back in the firing line
-
Treatment can last for years, but TB patients aren't infectious for the entire course of treatment.
WSJ: Dangerous TB Patient Nabbed On U.S. Border
-
Ashok Kumar, the head of the TB division, didn't return phone calls seeking comment.
WSJ: Plan to Fight Deadly TB Strain Advances in India
-
"We're not against culling badgers if it's going to be effective in curbing bovine TB, but you can't apply the criteria everywhere that would make it effective, " Mr Bullock told BBC News.
BBC: Badger vaccine pilot planned by National Trust in Devon
-
Mumbai made international headlines last year when a physician researcher reported several patients whose disease didn't respond to 12 of the most commonly used TB medicines.
WSJ: Plan to Fight Deadly TB Strain Advances in India
-
India has made enormous progress in TB control and to imply otherwise wouldn't accurately reflect the WHO's opinion.
WSJ: The WHO Supports India's Fight Against MDR-TB �� Letters to the Editor
-
Dr. Alpa Dalal, a chest physician at GTB Hospital, Mumbai's main TB hospital, said she has been warning government TB officials that the standard cocktail isn't working for many of her drug-resistant cases.
WSJ: TB Fight Hits a Wall in India
-
The problem, however, is that if a patient's TB is resistant to some of those drugs, the cocktail won't work.
WSJ: TB Fight Hits a Wall in India
-
Mumbai TB supervisors agree, saying some patients wait many months to get the right treatment because there aren't enough accredited labs to confirm diagnoses of more extreme drug resistance.
WSJ: Tuberculosis Strain in Mumbai Doesn't Respond to Main Treatment